The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

Alberta's decision to reduce access to publicly funded COVID-19 vaccines so far appears to set the province on a different ...

The vaccine is expected to be out of stock for a number of weeks, Foreign Office website Travel Health Pro today reported ...

The first measles vaccine was licensed in 1963 and became part of the combination measles, mumps, and rubella, or MMR, ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked ...

The group cast aside evidence-based science in favor of anti-vaccine propaganda and dangerous falsehoods that will hurt ...

A group of northeastern states, including Maine, New York, Rhode Island and Connecticut, are considering forming the group to ...

Moderna today reported promising relative vaccine efficacy (rVE) findings from a phase 3 trial of its seasonal mRNA flu ...